The last paragraph of the first section excludes allogeneic stem cells and Ryoncil is exactly that.
'This document does not address: stem cell therapy used for disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment (including transplantation of autologous or allogeneic stem cells), or autologous hematopoietic stem cell-based gene therapy.'
- Forums
- ASX - By Stock
- MSB
- Ann: Ryoncil Highlighted at Tandem Transplantation Meetings
MSB
mesoblast limited
Add to My Watchlist
2.33%
!
$2.52

Ann: Ryoncil Highlighted at Tandem Transplantation Meetings, page-130
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.52 |
Change
-0.060(2.33%) |
Mkt cap ! $3.225B |
Open | High | Low | Value | Volume |
$2.58 | $2.61 | $2.50 | $12.63M | 4.955M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8366 | $2.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.53 | 8780 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8366 | 2.510 |
1 | 3577 | 2.500 |
1 | 1204 | 2.490 |
2 | 8430 | 2.470 |
1 | 22300 | 2.460 |
Price($) | Vol. | No. |
---|---|---|
2.530 | 1289 | 2 |
2.540 | 3800 | 1 |
2.550 | 20000 | 1 |
2.580 | 40000 | 1 |
2.590 | 18880 | 2 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online